z-logo
open-access-imgOpen Access
Hepatitis C Virus and the Infectious Diseases Community
Author(s) -
Scott D. Holmberg
Publication year - 2012
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/cis360
Subject(s) - medicine , hepatitis c virus , cirrhosis , hepatitis c , diabetes mellitus , immunology , virus , intensive care medicine , endocrinology
It is a perfect storm for the chronic viral infection associated with the greatest morbidity and mortality in the United States. Of the ≥3 million Americans infected with hepatitis C virus (HCV), only ≤50% know they are infected. Infections acquired many years ago from parenteral exposures—injection drug use, transfusions received before screening assay availability (in 1992), or other healthcare exposures—have either no or nonspecific (but highly prevalent) symptoms, such as fatigue, arthritis, and depression. Clinicians tend to discount the extrahepatic effects of HCV infection, although HCV has been associated with diabetes and other serious morbidities. Now, after latencies of 20–30 years, there are rapidly increasing cases of cirrhosis,end-stageliverdisease,hepatocellularcarcinoma,

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom